These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1895293)
21. Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. Dunbar PG; Durant GJ; Rho T; Ojo B; Huzl JJ; Smith DA; el-Assadi AA; Sbeih S; Ngur DO; Periyasamy S J Med Chem; 1994 Aug; 37(17):2774-82. PubMed ID: 8064804 [TBL] [Abstract][Full Text] [Related]
22. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors. Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596 [TBL] [Abstract][Full Text] [Related]
23. [Relationship between analgesic activity and opiate receptor binding affinity of 5 derivatives of 3-aza-bicyclo(3,3,1)nonanes]. Wang DY; Chi ZQ Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):158-63. PubMed ID: 6095589 [No Abstract] [Full Text] [Related]
24. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists. Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297 [TBL] [Abstract][Full Text] [Related]
26. AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease. Fisher A; Brandeis R; Bar-Ner RH; Kliger-Spatz M; Natan N; Sonego H; Marcovitch I; Pittel Z J Mol Neurosci; 2002; 19(1-2):145-53. PubMed ID: 12212772 [TBL] [Abstract][Full Text] [Related]
27. Towards a high-affinity allosteric enhancer at muscarinic M1 receptors. Lazareno S; Popham A; Birdsall NJ J Mol Neurosci; 2002; 19(1-2):123-7. PubMed ID: 12212769 [TBL] [Abstract][Full Text] [Related]
28. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes. Arnt J; Lembøl HL; Meier E; Pedersen H Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027 [TBL] [Abstract][Full Text] [Related]
29. Conformational aspects of the muscarinic receptor interactions of bicyclic isoxazole ester bioisosteres of arecoline. Lagersted A; Falch E; Ebert B; Krogsgaard-Larsen P Drug Des Discov; 1993; 9(3-4):237-50. PubMed ID: 8400005 [TBL] [Abstract][Full Text] [Related]
31. Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain. Roman S; Vivas NM; Badia A; Clos MV Neurosci Lett; 2002 Jun; 325(2):103-6. PubMed ID: 12044632 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of 5-(4-alkylsulfanyl-[1, 2, 5]thiadiazol-3-yl)-3-methyl-1, 2, 3, 4-tetrahydropyrimidine oxalate salts and their evaluation as muscarinic receptor agonists. Jung MH; Park JG; Park WK Arch Pharm (Weinheim); 2003 Jul; 336(4-5):230-5. PubMed ID: 12916057 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro biological profile of all four isomers of the potent muscarinic agonist 3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo[2.2.1]heptane. Showell GA; Baker R; Davis J; Hargreaves R; Freedman SB; Hoogsteen K; Patel S; Snow RJ J Med Chem; 1992 Mar; 35(5):911-6. PubMed ID: 1548680 [TBL] [Abstract][Full Text] [Related]
34. Bioisosteric replacement strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors. Olesen PH; Tønder JE; Hansen JB; Hansen HC; Rimvall K Bioorg Med Chem; 2000 Jun; 8(6):1443-50. PubMed ID: 10896121 [TBL] [Abstract][Full Text] [Related]
35. Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A1. Holzgrabe U; Decker M Expert Opin Ther Pat; 2017 Feb; 27(2):121-125. PubMed ID: 27967250 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists. Tsukamoto S; Nagaoka H; Igarashi S; Wanibuchi F; Hidaka K; Tamura T Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1523-9. PubMed ID: 7586076 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors. Aagaard P; McKinney M J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H Khanfar MA; Reiner D; Hagenow S; Stark H Bioorg Med Chem; 2018 Aug; 26(14):4034-4046. PubMed ID: 29960729 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers. Wang LY; Wang Y; Zheng JQ; Zhong BH; Liu H; Dong SJ; Ruan JX; Liu KL Acta Pharmacol Sin; 2005 May; 26(5):527-32. PubMed ID: 15842768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]